Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection

BACKGROUND: Feline leukaemia virus (FeLV) is a pathogen causing fatal illness in cats worldwide, and as such there is a high demand for products to protect against disease. The duration of immunity provided by an inactivated FeLV vaccine, Versifel FeLV, when administered to cats of the target age wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Stephen, Greenslade, Juliet, Saunders, Gillian, Holcroft, Catherine, Bruce, Lynn, Scobey, Andy, Childers, Tedd, Sture, Gordon, Thompson, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433334/
https://www.ncbi.nlm.nih.gov/pubmed/22839692
http://dx.doi.org/10.1186/1746-6148-8-125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433334/
https://www.ncbi.nlm.nih.gov/pubmed/22839692
http://dx.doi.org/10.1186/1746-6148-8-125

Ejemplares similares